UBL3 and neurodegenerative disease: If the relationship between RNA metabolism and protein transport to sEVs in neurodegenerative diseases is elucidated, compounds that affect UBL3 modification may become novel drug candidates, employing innovative therapeutic strategies for neurodegenerative diseases involving RNA metabolism.